Beta-endorphins, which are naturally occurring narcotic substances, have been shown to alter
the perception of breathlessness. Oral ketoconazole, an antifungal antibiotic, increases
blood levels of beta-endorphins. The study hypothesis is that oral ketoconazole will reduce
ratings of breathlessness induced by resistive breathing loads.